Cargando…
Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP(+) by Transporter-Independent Export of the Intermediate MPDP(+)
Aims: 1-Methyl-4-phenyl-tetrahydropyridine (MPTP) is among the most widely used neurotoxins for inducing experimental parkinsonism. MPTP causes parkinsonian symptoms in mice, primates, and humans by killing a subpopulation of dopaminergic neurons. Extrapolations of data obtained using MPTP-based par...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649766/ https://www.ncbi.nlm.nih.gov/pubmed/26413876 http://dx.doi.org/10.1089/ars.2015.6297 |
_version_ | 1782401412306567168 |
---|---|
author | Schildknecht, Stefan Pape, Regina Meiser, Johannes Karreman, Christiaan Strittmatter, Tobias Odermatt, Meike Cirri, Erica Friemel, Anke Ringwald, Markus Pasquarelli, Noemi Ferger, Boris Brunner, Thomas Marx, Andreas Möller, Heiko M. Hiller, Karsten Leist, Marcel |
author_facet | Schildknecht, Stefan Pape, Regina Meiser, Johannes Karreman, Christiaan Strittmatter, Tobias Odermatt, Meike Cirri, Erica Friemel, Anke Ringwald, Markus Pasquarelli, Noemi Ferger, Boris Brunner, Thomas Marx, Andreas Möller, Heiko M. Hiller, Karsten Leist, Marcel |
author_sort | Schildknecht, Stefan |
collection | PubMed |
description | Aims: 1-Methyl-4-phenyl-tetrahydropyridine (MPTP) is among the most widely used neurotoxins for inducing experimental parkinsonism. MPTP causes parkinsonian symptoms in mice, primates, and humans by killing a subpopulation of dopaminergic neurons. Extrapolations of data obtained using MPTP-based parkinsonism models to human disease are common; however, the precise mechanism by which MPTP is converted into its active neurotoxic metabolite, 1-methyl-4-phenyl-pyridinium (MPP(+)), has not been fully elucidated. In this study, we aimed to address two unanswered questions related to MPTP toxicology: (1) Why are MPTP-converting astrocytes largely spared from toxicity? (2) How does MPP(+) reach the extracellular space? Results: In MPTP-treated astrocytes, we discovered that the membrane-impermeable MPP(+), which is generally assumed to be formed inside astrocytes, is almost exclusively detected outside of these cells. Instead of a transporter-mediated export, we found that the intermediate, 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP(+)), and/or its uncharged conjugate base passively diffused across cell membranes and that MPP(+) was formed predominately by the extracellular oxidation of MPDP(+) into MPP(+). This nonenzymatic extracellular conversion of MPDP(+) was promoted by O(2), a more alkaline pH, and dopamine autoxidation products. Innovation and Conclusion: Our data indicate that MPTP metabolism is compartmentalized between intracellular and extracellular environments, explain the absence of toxicity in MPTP-converting astrocytes, and provide a rationale for the preferential formation of MPP(+) in the extracellular space. The mechanism of transporter-independent extracellular MPP(+) formation described here indicates that extracellular genesis of MPP(+) from MPDP is a necessary prerequisite for the selective uptake of this toxin by catecholaminergic neurons. Antioxid. Redox Signal. 23, 1001–1016. |
format | Online Article Text |
id | pubmed-4649766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Mary Ann Liebert, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-46497662015-12-02 Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP(+) by Transporter-Independent Export of the Intermediate MPDP(+) Schildknecht, Stefan Pape, Regina Meiser, Johannes Karreman, Christiaan Strittmatter, Tobias Odermatt, Meike Cirri, Erica Friemel, Anke Ringwald, Markus Pasquarelli, Noemi Ferger, Boris Brunner, Thomas Marx, Andreas Möller, Heiko M. Hiller, Karsten Leist, Marcel Antioxid Redox Signal Original Research Communications Aims: 1-Methyl-4-phenyl-tetrahydropyridine (MPTP) is among the most widely used neurotoxins for inducing experimental parkinsonism. MPTP causes parkinsonian symptoms in mice, primates, and humans by killing a subpopulation of dopaminergic neurons. Extrapolations of data obtained using MPTP-based parkinsonism models to human disease are common; however, the precise mechanism by which MPTP is converted into its active neurotoxic metabolite, 1-methyl-4-phenyl-pyridinium (MPP(+)), has not been fully elucidated. In this study, we aimed to address two unanswered questions related to MPTP toxicology: (1) Why are MPTP-converting astrocytes largely spared from toxicity? (2) How does MPP(+) reach the extracellular space? Results: In MPTP-treated astrocytes, we discovered that the membrane-impermeable MPP(+), which is generally assumed to be formed inside astrocytes, is almost exclusively detected outside of these cells. Instead of a transporter-mediated export, we found that the intermediate, 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP(+)), and/or its uncharged conjugate base passively diffused across cell membranes and that MPP(+) was formed predominately by the extracellular oxidation of MPDP(+) into MPP(+). This nonenzymatic extracellular conversion of MPDP(+) was promoted by O(2), a more alkaline pH, and dopamine autoxidation products. Innovation and Conclusion: Our data indicate that MPTP metabolism is compartmentalized between intracellular and extracellular environments, explain the absence of toxicity in MPTP-converting astrocytes, and provide a rationale for the preferential formation of MPP(+) in the extracellular space. The mechanism of transporter-independent extracellular MPP(+) formation described here indicates that extracellular genesis of MPP(+) from MPDP is a necessary prerequisite for the selective uptake of this toxin by catecholaminergic neurons. Antioxid. Redox Signal. 23, 1001–1016. Mary Ann Liebert, Inc. 2015-11-01 /pmc/articles/PMC4649766/ /pubmed/26413876 http://dx.doi.org/10.1089/ars.2015.6297 Text en © Stefan Schildknecht et al. 2015; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Original Research Communications Schildknecht, Stefan Pape, Regina Meiser, Johannes Karreman, Christiaan Strittmatter, Tobias Odermatt, Meike Cirri, Erica Friemel, Anke Ringwald, Markus Pasquarelli, Noemi Ferger, Boris Brunner, Thomas Marx, Andreas Möller, Heiko M. Hiller, Karsten Leist, Marcel Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP(+) by Transporter-Independent Export of the Intermediate MPDP(+) |
title | Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP(+) by Transporter-Independent Export of the Intermediate MPDP(+) |
title_full | Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP(+) by Transporter-Independent Export of the Intermediate MPDP(+) |
title_fullStr | Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP(+) by Transporter-Independent Export of the Intermediate MPDP(+) |
title_full_unstemmed | Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP(+) by Transporter-Independent Export of the Intermediate MPDP(+) |
title_short | Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP(+) by Transporter-Independent Export of the Intermediate MPDP(+) |
title_sort | preferential extracellular generation of the active parkinsonian toxin mpp(+) by transporter-independent export of the intermediate mpdp(+) |
topic | Original Research Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649766/ https://www.ncbi.nlm.nih.gov/pubmed/26413876 http://dx.doi.org/10.1089/ars.2015.6297 |
work_keys_str_mv | AT schildknechtstefan preferentialextracellulargenerationoftheactiveparkinsoniantoxinmppbytransporterindependentexportoftheintermediatempdp AT paperegina preferentialextracellulargenerationoftheactiveparkinsoniantoxinmppbytransporterindependentexportoftheintermediatempdp AT meiserjohannes preferentialextracellulargenerationoftheactiveparkinsoniantoxinmppbytransporterindependentexportoftheintermediatempdp AT karremanchristiaan preferentialextracellulargenerationoftheactiveparkinsoniantoxinmppbytransporterindependentexportoftheintermediatempdp AT strittmattertobias preferentialextracellulargenerationoftheactiveparkinsoniantoxinmppbytransporterindependentexportoftheintermediatempdp AT odermattmeike preferentialextracellulargenerationoftheactiveparkinsoniantoxinmppbytransporterindependentexportoftheintermediatempdp AT cirrierica preferentialextracellulargenerationoftheactiveparkinsoniantoxinmppbytransporterindependentexportoftheintermediatempdp AT friemelanke preferentialextracellulargenerationoftheactiveparkinsoniantoxinmppbytransporterindependentexportoftheintermediatempdp AT ringwaldmarkus preferentialextracellulargenerationoftheactiveparkinsoniantoxinmppbytransporterindependentexportoftheintermediatempdp AT pasquarellinoemi preferentialextracellulargenerationoftheactiveparkinsoniantoxinmppbytransporterindependentexportoftheintermediatempdp AT fergerboris preferentialextracellulargenerationoftheactiveparkinsoniantoxinmppbytransporterindependentexportoftheintermediatempdp AT brunnerthomas preferentialextracellulargenerationoftheactiveparkinsoniantoxinmppbytransporterindependentexportoftheintermediatempdp AT marxandreas preferentialextracellulargenerationoftheactiveparkinsoniantoxinmppbytransporterindependentexportoftheintermediatempdp AT mollerheikom preferentialextracellulargenerationoftheactiveparkinsoniantoxinmppbytransporterindependentexportoftheintermediatempdp AT hillerkarsten preferentialextracellulargenerationoftheactiveparkinsoniantoxinmppbytransporterindependentexportoftheintermediatempdp AT leistmarcel preferentialextracellulargenerationoftheactiveparkinsoniantoxinmppbytransporterindependentexportoftheintermediatempdp |